These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 19187586)

  • 1. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between late incomplete stent apposition after sirolimus eluting stent implantation and clinical outcomes in patients with acute coronary syndrome].
    Zhang RY; Du R; Zhu ZB; Zhang Q; Hu J; Ding FH; Lü AK; Zhang JS; Shen WF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):30-4. PubMed ID: 19671348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
    Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
    Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of late-acquired incomplete stent apposition after drug-eluting stent versus bare-metal stent. A meta-analysis from 12 randomized trials.
    Sanchez-Recalde A; Moreno R; Barreales L; Rivero F; Galeote G; Jimenez-Valero S; Calvo L; López de Sá E; López-Sendón JL
    J Invasive Cardiol; 2008 Aug; 20(8):417-22. PubMed ID: 18688067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A more than 2-year follow-up of incomplete apposition after drug-eluting stent implantation.
    Qian JY; Zhang F; Fan B; Ge L; Wang QB; Ge JB
    Chin Med J (Engl); 2008 Mar; 121(6):498-502. PubMed ID: 18364132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
    Zhang F; Qian J; Ge J
    J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
    Tanabe K; Serruys PW; Degertekin M; Grube E; Guagliumi G; Urbaszek W; Bonnier J; Lablanche JM; Siminiak T; Nordrehaug J; Figulla H; Drzewiecki J; Banning A; Hauptmann K; Dudek D; Bruining N; Hamers R; Hoye A; Ligthart JM; Disco C; Koglin J; Russell ME; Colombo A;
    Circulation; 2005 Feb; 111(7):900-5. PubMed ID: 15710761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes.
    Siqueira DA; Abizaid AA; Costa Jde R; Feres F; Mattos LA; Staico R; Abizaid AA; Tanajura LF; Chaves A; Centemero M; Sousa AG; Sousa JE
    Eur Heart J; 2007 Jun; 28(11):1304-9. PubMed ID: 17478457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.
    Park DW; Park SW; Park KH; Lee BK; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2006 Aug; 98(3):352-6. PubMed ID: 16860022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance alone.
    Fujimoto H; Tao S; Dohi T; Ito S; Masuda J; Haruo M; Fujimoto Y; Maehara A; Yamaguchi T; Ishiwata S; Ohno M
    J Cardiol; 2008 Feb; 51(1):18-24. PubMed ID: 18522771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials.
    Hoffmann R; Morice MC; Moses JW; Fitzgerald PJ; Mauri L; Breithardt G; Schofer J; Serruys PW; Stoll HP; Leon MB
    Heart; 2008 Mar; 94(3):322-8. PubMed ID: 17761505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes after bioabsorbable polymer- and durable polymer-based sirolimus-eluting stents implantation: two-year follow-up results from a large single-center database.
    Liu HB; Xu B; Yang YJ; Wang Y; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Ma WH; Li JJ; Qiao SB; Chen JL; Li W; Gao RL
    Chin Med J (Engl); 2009 Mar; 122(6):681-6. PubMed ID: 19323934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).
    Roy P; Bonello L; de Labriolle A; Okabe T; Pinto Slottow TL; Steinberg DH; Torguson R; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2008 Aug; 102(3):292-7. PubMed ID: 18638589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience of sirolimus-eluting stents in patients with coronary artery disease at Bangkok Heart Institute.
    Lolekha P; Bhuripanyo K; Kukreja R; Mahanonda N; Numee M
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S76-82. PubMed ID: 12866772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of sirolimus-eluting stent implantation in patients with acute coronary syndrome in the real world.
    Kawaguchi R; Kimura T; Morimoto T; Oshima S; Hoshizaki H; Kawai K; Shiode N; Hiasa Y; Mitsudo K;
    Am J Cardiol; 2010 Dec; 106(11):1550-60. PubMed ID: 21094354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
    J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis.
    Degertekin M; Serruys PW; Tanabe K; Lee CH; Sousa JE; Colombo A; Morice MC; Ligthart JM; de Feyter PJ
    Circulation; 2003 Dec; 108(22):2747-50. PubMed ID: 14638542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation.
    Cook S; Eshtehardi P; Kalesan B; Räber L; Wenaweser P; Togni M; Moschovitis A; Vogel R; Seiler C; Eberli FR; Lüscher T; Meier B; Jüni P; Windecker S
    Eur Heart J; 2012 Jun; 33(11):1334-43. PubMed ID: 22285579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.